Efficacy and safety of Actovegin for stroke rehabilitation: systematic review.

Simple item page
dc.contributor.authorBaizhaxynova, Ardak
dc.date.accessioned2019-07-05T06:14:50Z
dc.date.available2019-07-05T06:14:50Z
dc.date.issued2019
dc.description.abstractStroke is a non-communicable disease, which causes death and morbidity worldwide with 68 per cent incidence of the ischemic stroke and 32 per cent incidence of hemorrhagic stroke (intracerebral haemorrhage and subarachnoid haemorrhage combined) (Institute for Health Metrics and Evaluation, 2018). In Kazakhstan stroke is both the second leading cause of premature death and loss of disability-adjusted life years ("Kazakhstan", 2017). The condition causes a broad umbrella of complications including deep vein thrombosis, seizures, pneumonia, cognitive decline, depression, cerebral oedema, bladder problems, pressure sores, neurologic deficits and contractures (Oliveira Filho & T Mullen, 2019).en_US
dc.identifier.citationBaizhaxynova, Ardak (2019) Efficacy and safety of Actovegin for stroke rehabilitation: systematic review. Nazarbayev University School of Medicine.en_US
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/3939
dc.language.isoenen_US
dc.publisherNazarbayev University School of Medicineen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectstrokeen_US
dc.titleEfficacy and safety of Actovegin for stroke rehabilitation: systematic review.en_US
dc.typeMaster's thesisen_US
workflow.import.sourcescience

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

02. Master's Thesis